Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Shuttle Pharmaceuticals Holdings, Inc. ( (SHPH) ) has shared an update.
On June 20, 2025, Shuttle Pharmaceuticals Holdings, Inc. entered into a securities purchase agreement with an accredited investor for a private placement of 21,924 shares of common stock and 1,158,953 pre-funded warrants, closing on June 24, 2025. The transaction, facilitated by WestPark Capital, Inc., is valued at $4.25 million and aims to support potential acquisitions, marketing, and general corporate purposes. The company is required to file a registration statement with the SEC for the resale of these securities, with specific deadlines to avoid liquidated damages. This strategic move is expected to bolster Shuttle Pharma’s financial position and support its mission to improve cancer treatment outcomes.
Spark’s Take on SHPH Stock
According to Spark, TipRanks’ AI Analyst, SHPH is a Underperform.
Shuttle Pharmaceuticals Holdings, Inc. faces significant financial challenges with no revenue and ongoing cash burn. Technical indicators show bearish trends, and valuation metrics highlight the company’s unprofitability. While recent corporate activities offer potential strategic benefits, they also add financial strain and governance complexities, leading to an overall low stock score.
To see Spark’s full report on SHPH stock, click here.
More about Shuttle Pharmaceuticals Holdings, Inc.
Shuttle Pharmaceuticals Holdings, Inc. is a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy. The company’s mission is to enhance the effectiveness of radiation therapy while minimizing its side effects, aiming to increase cancer cure rates, prolong patient survival, and improve quality of life.
Average Trading Volume: 239,885
Technical Sentiment Signal: Sell
Current Market Cap: $3.63M
Learn more about SHPH stock on TipRanks’ Stock Analysis page.